UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

Leukemia research, 2018-12, Vol.75, p.29-35

2018

Volltextzugriff (PDF)

Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy

Leukemia & lymphoma, 2021-06, Vol.62 (7), p.1778-1781

2021

Volltextzugriff (PDF)

Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21 (9), p.613-620

2021

Volltextzugriff (PDF)

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.131-4, Article 131

2023

Volltextzugriff (PDF)

Spectral domain optical coherence tomography for detection of foveal morphology in patients with nystagmus

Journal of AAPOS, 2009-12, Vol.13 (6), p.563-566

2009

Volltextzugriff (PDF)

Accuracy and performance of a commercially available Dosing Aid

British journal of ophthalmology, 2007-04, Vol.91 (4), p.497-499

2007

Volltextzugriff (PDF)

Increased Monocytic Myeloid-Derived Suppressor Cells in the Marrow of Relapsed/Refractory Acute Myeloid Leukemia Patients Following Induction Chemotherapy

Blood, 2018-11, Vol.132 (Supplement 1), p.5270-5270

2018

Volltextzugriff (PDF)

Addition of the PARP Inhibitor, Talazoparib, to Gemtuzumab Ozogamicin Significantly Enhances Anti-Leukemic Activity in Human CD33+ Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.1371-1371

2019

Volltextzugriff (PDF)

ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

Leukemia, 2024-01, Vol.38 (1), p.210-214

2024

Volltextzugriff (PDF)

MRD Status and ELN 2022 Predicts for Outcomes of Venetoclax + Hypomethylating Therapy in AML: Single-Center Real-World Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.9010-9012

2022

Volltextzugriff (PDF)

013: Spectral domain optical coherence tomography in patients with nystagmus

Journal of AAPOS, 2009, Vol.13 (1), p.e3-e4

2009

Volltextzugriff (PDF)

Chloroquine Derivative Lys05 Overcomes Hypoxia-Induced Chemoresistance in Acute Myeloid Leukemia through Metabolic Disruption

Blood, 2018-11, Vol.132 (Supplement 1), p.3948-3948

2018

Volltextzugriff (PDF)

A Randomized Trial Comparing Bilateral Lateral Rectus Recession versus Unilateral Recess and Resect for Basic-Type Intermittent Exotropia

Ophthalmology (Rochester, Minn.), 2019-02, Vol.126 (2), p.305-317

2019

Volltextzugriff (PDF)

Outcomes of Venetoclax-Based Regimens Compared with Hypomethylating Agents (HMA) Alone or 7+3 in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): A Single Center Retrospective Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.3866-3866

2019

Volltextzugriff (PDF)

Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.1361-1361

2019

Volltextzugriff (PDF)

Mitophagy Plays a Key Role in the Anti-Leukemic Activity of Autophagy Inhibitors Under Hypoxia in Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.1278-1278

2019

Volltextzugriff (PDF)

Graded partial tenotomy of vertical rectus muscles for treatment of hypertropia

Transactions of the American Ophthalmological Society, 2004, Vol.102, p.169-75; discussion 175-6

2004

Volltextzugriff (PDF)

Synergistic Anti-Leukemic Activity of PARP Inhibition Combined with IMGN632, an Anti-CD123 Antibody-Drug Conjugate in Acute Myeloid Leukemia Models

Blood, 2018-11, Vol.132 (Supplement 1), p.2647-2647

2018

Volltextzugriff (PDF)

Clinical and Molecular Variables Associated with Atherosclerotic Vascular Disease in Myelodysplastic Syndromes

Blood, 2018-11, Vol.132 (Supplement 1), p.4366-4366

2018

Volltextzugriff (PDF)

Intensive Chemotherapy Vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience

Blood, 2017-12, Vol.130, p.2620-2620

2017

Volltextzugriff (PDF)

Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.131-131

2023

Volltextzugriff (PDF)

Relationships among Clinical Factors and Patient-reported Outcome Measures in Adults with Convergence Insufficiency

Optometry and vision science, 2022-09, Vol.99 (9), p.692

2022

Volltextzugriff (PDF)

Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience

Clinical lymphoma, myeloma and leukemia, 2017-09, Vol.17, p.S288-S289

2017

Volltextzugriff (PDF)

细胞分离培养在实验室诊断眼部单纯疱疹病毒感染疾病的误诊和漏诊情况

Guo ji yan ke za zhi, 2010, Vol.10 (11), p.2045-2048

Regis P Kowalski Paul P Thompson Tara H Cronin

2010

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(10)
Stroke
(10)
Advances In Simulation
(3)
Blood Cancer Journal
(2)
Clinical Lymphoma, Myeloma And Leukemia
(2)
Hrb Open Research
(2)
Journal Of Aapos
(2)
Journal Of Nutrition Education And Behavior
(2)
Leukemia
(2)
Altex
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy

Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Spectral domain optical coherence tomography for detection of foveal morphology in patients with nystagmus

Accuracy and performance of a commercially available Dosing Aid

Increased Monocytic Myeloid-Derived Suppressor Cells in the Marrow of Relapsed/Refractory Acute Myeloid Leukemia Patients Following Induction Chemotherapy

Addition of the PARP Inhibitor, Talazoparib, to Gemtuzumab Ozogamicin Significantly Enhances Anti-Leukemic Activity in Human CD33+ Acute Myeloid Leukemia

ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

MRD Status and ELN 2022 Predicts for Outcomes of Venetoclax + Hypomethylating Therapy in AML: Single-Center Real-World Analysis

Germline variants drive myelodysplastic syndrome in young adults

013: Spectral domain optical coherence tomography in patients with nystagmus

Chloroquine Derivative Lys05 Overcomes Hypoxia-Induced Chemoresistance in Acute Myeloid Leukemia through Metabolic Disruption

A Randomized Trial Comparing Bilateral Lateral Rectus Recession versus Unilateral Recess and Resect for Basic-Type Intermittent Exotropia

Outcomes of Venetoclax-Based Regimens Compared with Hypomethylating Agents (HMA) Alone or 7+3 in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): A Single Center Retrospective Analysis

Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Mitophagy Plays a Key Role in the Anti-Leukemic Activity of Autophagy Inhibitors Under Hypoxia in Acute Myeloid Leukemia

Graded partial tenotomy of vertical rectus muscles for treatment of hypertropia

Synergistic Anti-Leukemic Activity of PARP Inhibition Combined with IMGN632, an Anti-CD123 Antibody-Drug Conjugate in Acute Myeloid Leukemia Models

Clinical and Molecular Variables Associated with Atherosclerotic Vascular Disease in Myelodysplastic Syndromes

Intensive Chemotherapy Vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience

Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Relationships among Clinical Factors and Patient-reported Outcome Measures in Adults with Convergence Insufficiency

Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience

细胞分离培养在实验室诊断眼部单纯疱疹病毒感染疾病的误诊和漏诊情况

Suchergebnisse filtern